Over the past several months, we have seen a significant increase in audits and investigations targeting pharmacies for misrepresentations around prior authorization. In many of these audits, pharmacies are being accused of falsifying information or impersonating...
Receiving a subpoena from the Office of Inspector General (OIG) is a serious matter, often signaling a federal investigation into potential healthcare fraud or regulatory violations. These subpoenas require careful attention and a strategic response. As such, it is...
As healthcare providers look to streamline operations and improve efficiency, Management Service Organizations (“MSOs”) have become increasingly vital in helping medical practices, dental offices, and other healthcare entities manage non-clinical functions. MSOs...
The FDA has just granted the pharmaceutical industry a one-year extension on enforcing certain enhanced drug distribution security requirements. With the original compliance deadline set for November 27, 2023, the FDA's decision comes in response to industry...